Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
329 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Currently Recruiting (1)
  • Closed (2)

Medical Condition

  • Show all (45)
  • Cancer (27)
    • Bladder Cancer (2)
    • Brain Cancer (4)
    • Breast Cancer (7)
    • Gastrointestinal (1)
    • Gynecologic Cancer (3)
    • Lung Cancer (5)
    • Pancreatic Cancer (2)
    • (-) Skin Cancer (2)
      • Melanoma (2)
  • Healthy Volunteers (1)
  • Heart Disease (3)
  • Infectious Disease (1)
  • Neurological Disorders (3)
  • Obesity (1)
  • (-) Obstetrics & Gynecology (1)
  • Pediatrics (5)
  • Surgery (1)
  • Transplant (1)
  • Vascular Conditions (1)
Displaying 1 - 3 of 3

Have You Had a Hysterectomy, a Tubal Ligation, or Another Type of Sterilization Surgery? Share your experience!

Condition: Obstetrics & Gynecology
Investigator: Xiao Xu, PhD
Status: Currently Recruiting
Columbia University researchers are looking to interview people for a study on patient decisions about whether to remove the fallopian tubes when having a hysterectomy, tubal ligation, or other sterilization surgery. If you are a woman 30-49 years of age, speak English, and have had a hysterectomy (for non-cancer reasons),…
Read More

Study of Fianlimab and Cemiplimab vs. Pembrolizumab in Patients with Resected High-Risk Melanoma

Condition: Skin Cancer / Melanoma
Investigator: Benjamin Izar, MD
Status: Closed
The purpose of this study is to see if the combination of fianlimab (REGN3767) and cemiplimab (REGN2810) is an effective treatment compared to pembrolizumab in participants that have had melanoma removal surgery but are still at high risk for the return of the disease. This study involves 2 study drugs: fianlimab (REGN3767)…
Read More

Study of V940 Plus Pembrolizumab in Patients With High-Risk Melanoma

Condition: Skin Cancer / Melanoma
Investigator: Benjamin Izar, MD
Status: Closed
The purpose of this study is to compare V940 plus pembro given after surgery to a placebo plus pembro given after surgery and to study how effective the study drug is. A placebo looks like a study drug, but it has no active ingredients. V940 has not yet been approved by the Food and Drug…
Read More
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2025 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science